Financial Ratios

ARTILLEGENCE BIO-INNOVATIONS LTD.

NSE : NABSE : 512642ISIN CODE : INE576F01010Industry : Finance - InvestmentHouse : Private
BSE3.470 (0 %)
PREV CLOSE ( ) 3.47
OPEN PRICE ( ) 3.47
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3.72 (611)
VOLUME 289
TODAY'S LOW / HIGH ( )3.47 3.47
52 WK LOW / HIGH ( ) 3.473.47
NSE
This Company is not listed in NSE
Select year
ParticularsMar2012Mar2011Mar2010Mar2009Mar2008
Operational & Financial Ratios
   Earnings Per Share (Rs)0.01-0.390.010.010.00
   CEPS(Rs)0.01-0.390.010.010.00
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)35.9835.9836.3636.3636.34
   Tax Rate(%)0.00-0.412.010.757.43
Margin Ratios
   Core EBITDA Margin(%)-0.23-3.580.01-0.14-0.10
   EBIT Margin(%)0.27-2.940.040.100.09
   Pre Tax Margin(%)0.17-2.940.030.100.05
   PAT Margin (%)0.17-2.950.030.100.05
   Cash Profit Margin (%)0.17-2.950.030.100.05
Performance Ratios
   ROA(%)0.01-0.900.010.030.01
   ROE(%)0.01-1.070.010.040.01
   ROCE(%)0.02-1.060.020.040.02
   Asset Turnover(x)0.090.310.320.280.15
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)0.110.530.591.100.17
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.000.000.000.00
   Receivable days258.9245.7028.4271.73301.76
   Inventory Days961.61261.26172.88204.46591.78
   Payable days54.2243.51105.6396.220.20
Valuation Parameters
   PER(x)0.000.00530.92116.531088.07
   PCE(x)0.00-6.87530.92116.531088.07
   Price/Book(x)0.000.070.080.040.09
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)3.090.200.110.080.52
   EV/Core EBITDA(x)1165.24-6.78259.1081.90560.31
   EV/EBIT(x)1165.24-6.78259.1081.90560.31
   EV/CE(x)0.280.070.040.020.07
   M Cap / Sales0.000.200.170.110.54
Growth Ratio
   Net Sales Growth(%)-75.29-18.8919.16123.14-61.57
   Core EBITDA Growth(%)102.23-5605.90-49.13142.9490.44
   EBIT Growth(%)102.23-5605.90-49.13142.9490.44
   PAT Growth(%)101.39-7602.54-60.32329.8747.32
   EPS Growth(%)101.39-7602.54-60.32329.8747.32
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)0.0026.933.261.726.42
   Quick Ratio(x)0.0020.782.191.584.43
   Interest Cover(x)2.67-2408.634.0420.932.36
   Total Debt/Mcap(x)0.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.